ASML Holding NV investors told to turn to BFA law ahead of January 13 class action deadline Investing.com
New York, New York–(Newsfile Corp. – January 4, 2025) – A leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class-action lawsuit alleging violations of federal securities laws against ASML Holding NV (NASDAQ: AS: ) and certain of the Company’s senior executives.
If you have invested in ASML, we encourage you to do so you can get additional information by visiting https://www.bfalaw.com/cases-investigations/asml-holding-nv.
Investors have until January 13, 2025 to ask the court to appoint them to manage the case. The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ASML common stock, call options and/or put options. The case is pending in the US District Court for the Southern District of New York and is subtitled Matar v. ASML Holding NV, et al.number 24-cv-9908.
What is the lawsuit about?
ASML is a leading supplier to the semiconductor industry, providing chipmakers with photolithography machines used in the semiconductor manufacturing process.
The lawsuit alleges that ASML repeatedly represented to shareholders that new semiconductor technology export controls announced by the Dutch government would not have a significant effect on ASML’s financial prospects and that ASML was on track to recover its sales.
On October 15, 2024, ASML reported significantly lower than expected earnings. The company attributed this to the market “taking longer to recover” and admitted that “[i]the recovery now appears to be more gradual than previously expected.” Following this news, the Company’s share price fell 16%, from a closing price of $872.27 per share on October 14, 2024, to $730.43 per share October 15, 2024.
Then, during the accompanying earnings call with investors on October 16, 2024, the Company attributed the poor earnings results to “a reflection of the slow recovery of the traditional [semiconductor] end markets as buyers remain cautious in the current environment.” The company also disclosed that a decline in ASML sales in China would also negatively impact the Company’s gross margins. Following this news, the Company’s share price fell 6.4% from closing price of $730.43 per share on October 15, 2024, to $683.52 per share on October 16, 2024.
Click here if you have suffered losses: https://www.bfalaw.com/cases-investigations/asml-holding-nv.
What can you do?
If you have invested in ASML, you may have legal options and we encourage you to submit your information to the company.
All representation is on a contingency fee basis, at no cost to you. Shareholders are not responsible for any court costs or litigation expenses. The Company will seek court approval for all potential fees and costs.
Submit your information by visiting:
https://www.bfalaw.com/cases-investigations/asml-holding-nv
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. ISS SCAS named it one of the Top 5 Law Firms for Plaintiffs in 2023, Thompson Reuters named its attorneys Titans of the Plaintiffs Bar, and Thompson Reuters SuperLawyers. Among its recent notable successes, BFA recovered more than $900 million in value from Tesla (NASDAQ: ), Inc. board of directors (pending court approval), as well as $420 million from Teva Pharmaceutical (NYSE: ) Ind. Ltd.
For more information about BFA and its attorneys, visit https://www.bfalaw.com.
https://www.bfalaw.com/cases-investigations/asml-holding-nv
Advertising of lawyers. Past results do not guarantee future results.
To view the original version of this press release, visit https://www.newsfilecorp.com/release/235855
